United Therapeutics (UTHR) Accumulated Depreciation & Amortization (2016 - 2025)
Historic Accumulated Depreciation & Amortization for United Therapeutics (UTHR) over the last 16 years, with Q3 2025 value amounting to $62.8 million.
- United Therapeutics' Accumulated Depreciation & Amortization rose 1893.94% to $62.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $62.8 million, marking a year-over-year increase of 1893.94%. This contributed to the annual value of $72.5 million for FY2024, which is 3627.82% up from last year.
- Per United Therapeutics' latest filing, its Accumulated Depreciation & Amortization stood at $62.8 million for Q3 2025, which was up 1893.94% from $40.9 million recorded in Q2 2025.
- Over the past 5 years, United Therapeutics' Accumulated Depreciation & Amortization peaked at $72.5 million during Q4 2024, and registered a low of $12.5 million during Q1 2021.
- Its 5-year average for Accumulated Depreciation & Amortization is $35.9 million, with a median of $37.3 million in 2021.
- In the last 5 years, United Therapeutics' Accumulated Depreciation & Amortization crashed by 40.0% in 2021 and then soared by 3627.82% in 2024.
- Over the past 5 years, United Therapeutics' Accumulated Depreciation & Amortization (Quarter) stood at $49.9 million in 2021, then grew by 2.81% to $51.3 million in 2022, then increased by 3.7% to $53.2 million in 2023, then soared by 36.28% to $72.5 million in 2024, then fell by 13.38% to $62.8 million in 2025.
- Its Accumulated Depreciation & Amortization stands at $62.8 million for Q3 2025, versus $40.9 million for Q2 2025 and $19.8 million for Q1 2025.